- To learn about the best clinical practice in the multidisciplinary management of hereditary cancer syndromes
- To understand the molecular basis and heterogeneity of the genetic susceptibility to develop cancer
- To learn how to recognize, diagnose, treat and provide prevention recommendations to patients with a germline genetic susceptibility
Download the preliminary programme
How to apply
Application is via online form. During the application process you will be required to upload the following:
*All submitted clinical cases should focus on a genetic issue more than the oncology disease, with a key message of what has been learned.
Application for the course will close on Tuesday, 6 April 2021.
Who can apply?
While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.
Successful applicants will benefit from complimentary registration for this virtual course.
The programme of this virtual event has been accredited with 5 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Judith Balmaña, Spain
Nicoline Hoogerbrugge, Netherlands